Cargando…
Multi-dose enteral L-citrulline administration in premature infants at risk of developing pulmonary hypertension associated with bronchopulmonary dysplasia
OBJECTIVE. Information is needed to guide the design of randomized controlled trials (RCTs) evaluating L-citrulline as a therapy for premature infants with pulmonary hypertension associated with bronchopulmonary dysplasia (BPD-PH). Our goal was to evaluate the tolerability and ability to achieve a t...
Autores principales: | Aschner, Judy, Avachat, Charul, Birnbaum, Angela, Sherwin, Catherine, Fike, Candice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275028/ https://www.ncbi.nlm.nih.gov/pubmed/37333204 http://dx.doi.org/10.21203/rs.3.rs-3006963/v1 |
Ejemplares similares
-
Pharmacotherapy for Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Past, Present, and Future
por: Fike, Candice D., et al.
Publicado: (2023) -
Fetal Growth Restriction and Pulmonary Hypertension in Premature Infants with Bronchopulmonary Dysplasia
por: Check, Jennifer, et al.
Publicado: (2013) -
An Innovative Model of Bronchopulmonary Dysplasia in Premature Infants
por: Zhang, Xiaoyue, et al.
Publicado: (2020) -
Pulmonary Vascular Underperfusion Score in Premature Infants with Bronchopulmonary Dysplasia and Pulmonary Hypertension
por: Das, Bibhuti B., et al.
Publicado: (2019) -
In-hospital Outcomes of Premature Infants with Severe Bronchopulmonary Dysplasia
por: Jackson, Wesley, et al.
Publicado: (2017)